Frequently Asked Questions
Pacemakers, Defibrillators and Cardiac Resynchronization Therapy (CRT) are major product type of cardiac rhythm management devices, out of which defibrillators segment dominated the global market owing to rising cardiovascular diseases. Dominance of defibrillators segment will be continuing in the forecast period attributed to the technological innovations in the devices.
Some of the major players operating in Cardiac rhythm management devices industry include, Medtronic plc, Abbott laboratories, Schiller AG, Koninklijke Philips N.V., Boston Scientific Corporation and Microport Scientific Corporation. This is owing to increasing focus on effective monitoring from end user industries.
North America hold the highest market share owing to large demand of Cardiac rhythm management devices, increasing healthcare awareness among end users and growing demand in several industries.
The market is anticipated to grow at a CAGR of 4.5% throughout the forecast period, in terms of revenue
High cost involved in the treatment of Cardiac rhythm management devices industry. Moreover, lack of technical expertise of cardiac rhythm management device among end-users across emerging markets is one of the significant hurdle for the growth of this industry.